UK regulator approves Pfizer's new crown vaccine for children aged 12-15

The British drug regulator said on Friday that after a “rigorous review”, it believes that the Pfizer/BioNTech vaccine is safe for teenagers between 12 and 15 years of age.

The British drug regulator said on Friday that after a “rigorous review”, it believes that the Pfizer/BioNTech vaccine is safe for teenagers between 12 and 15 years of age.

Drugs and health products Regulatory Authority (MHRA) to younger people were in the clinical trial after clinical trial approved two injections, saying the vaccine vaccine has reached the safety, quality and efficacy of the "expected standard.

The government vaccination committee will now decide whether and when to start vaccination for the age group.

"We carefully reviewed the clinical trial data for children aged 12 to 15 and concluded that the Pfizer/BioNTech COVID-19 vaccine is safe and effective at this age, and the benefits of this vaccine outweigh any risks," MHRA Chief Executive Officer Joan Lane said.

"Unless the expected safety, quality and effectiveness standards are met, the extension of the authorization will not be approved.

Rehn added that the UK surveillance system used to monitor the safety of all approved COVID-19 vaccines will now include people aged 12 to 15 who receive the dose.

British regulators last month approved the European Medicines management approval Agency and the US Food and Drug Administration to allow younger people to accept Pfizer / BioNTech injection.

The United States has begun vaccinating young people, and EU member states will do so this month.

In December last year, the United Kingdom was the first Western country to start a mass immunization campaign.

Britain ten days in mid-May increased infection after a decline in the number to about 2,000 cases, the number of daily new infections UK exponential growth, new cases of 4261 cases June 2, seven days an average increase of value has reached 3486 cases.

Leave a message here